1KLAASSEN C D. Heavy metals and heavy-metal antagonists. In Hardman JG, Gilman AG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics[J]. New York McGraw-Hill, 1996:1649-1672.
2KWONG Y L, TODD D. Delicious poison: arsenic trioxide for thetreatment of leukernia[letter][J]. Blood, 1997,89 : 3487-3488.
3BAJ G, ARNULFO A, DEAGLIO S, et al. Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiation and immuno-modulatory effects[J]. Breast Cancer Res Treat, 2002,73 ( 1 ) : 61-73.
5ZHOU D C, GAO M, FERRARI A C, et al. Arsenic trioxide is an equipotent inducer of apoptosis in androgen-dependent and androgen-independent LNCaP prostate cancer cell sublinesJ-abstract 39991. Proc AACR,1998,39:588.
6ZHENG J (郑杰), DENG Y P, LIN C, et al. Arsenic trioxide induces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression[J]. Int Cancer, 1999,82 : 286-292.
7YANG C H, WANG T Y, CHEN Y C. Cytotoxicity of arsenic trioxide in cancer cell lines[abstract 1552][J]. Proc AACR, 1998, 39:227.
8XIAO Y F (肖延风), LIU S X, WU D D, et al. Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growthfactor in gastric cancer[J]. World J Gastroenterol, 2006,12(36) : 5780-5786.
